How do you pay?

How to pay the least

Ask for the cash price

Olpruva

The FDA has approved a generic, but it isn’t in pharmacies yet.

  1. Ask your pharmacy for Olpruva’s cash price, and one or two other pharmacies too.

Compare every option

Question
Brand nameOlpruva
Authorized genericsodium phenylbutyrate
Regular genericsodium phenylbutyrate
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNot in stores yet
Same as Olpruva?
The original
–
–

Brand nameThe maker’s card

AmplifyAssist commercial copay assistance program

Savings card from Acer Therapeutics (a Zevra Therapeutics company)

Olpruva’s maker has a savings program. Its page doesn’t list a dollar amount.

Sign up on olpruva.com 

Or call 1-888-668-4198.

From the maker’s site, checked November 2, 2026. Check the maker’s page for who can use it.

Authorized genericNot sold

There isn’t one. An authorized generic is Olpruva itself, from the same company, sold without the brand name, and usually for less. For now Olpruva is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

The FDA has approved a generic, but it isn’t in pharmacies yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says
  • OLPRUVA is a nitrogen-binding agent indicated as adjunctive therapy to standard of care, which includes dietary management, for the chronic management of adult and pediatric patients weighing 20 kg or greater and with a body surface area (BSA) of 1.2 m 2or greater, with urea cycle disorders (UCDs) involving deficiencies of carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic acid synthetase (AS).

Limitations of Use:

OLPRUVA is not indicated for the treatment of acute hyperammonemia.

Source: the FDA label for Olpruva (Acer Therapeutics Inc.), December 18, 2024. Full label on DailyMed 

Good to know